GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer
Authors:

Posted by Alumni
March 10, 2025
Background: Glucosamine 6-phosphate N-acetyltransferase (GNPNAT1) is a crucial enzyme involving hexosamine biosynthesis pathway and is upregulated in breast cancer (BRCA). However, its biological function and mechanism on patients in BRCA have not been investigated.
learn more on PubMed
ATTACHMENTS